Flagship Pioneering’s Sana Biotechnology SANA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$72M Hold
25,001,856
6.2% 3
2025
Q4
$102M Hold
25,001,856
31.4% 2
2025
Q3
$88.8M Hold
25,001,856
30.33% 2
2025
Q2
$68.3M Hold
25,001,856
25.42% 2
2025
Q1
$42M Hold
25,001,856
17.82% 3
2024
Q4
$40.8M Hold
25,001,856
12.19% 3
2024
Q3
$104M Hold
25,001,856
17.57% 3
2024
Q2
$137M Hold
25,001,856
16.19% 2
2024
Q1
$250M Hold
25,001,856
16.4% 2
2023
Q4
$102M Hold
25,001,856
7.7% 2
2023
Q3
$96.8M Sell
25,001,856
-8,288,162
-25% -$44.5M 7.02% 2
2023
Q2
$198M Sell
33,290,018
-949,000
-3% -$5.47M 8.85% 2
2023
Q1
$112M Hold
34,239,018
4.35% 4
2022
Q4
$135M Hold
34,239,018
4.32% 3
2022
Q3
$205M Hold
34,239,018
8.65% 2
2022
Q2
$220M Hold
34,239,018
8.29% 2
2022
Q1
$283M Hold
34,239,018
6.64% 2
2021
Q4
$530M Hold
34,239,018
8.19% 2
2021
Q3
$771M Hold
34,239,018
8.07% 2
2021
Q2
$673M Hold
34,239,018
8.6% 3
2021
Q1
$1.15B Buy
+34,239,018
New +$1.11B 18.35% 2

Other funds holding SANA